Hardeep S. Oberoi

1.1k total citations
18 papers, 909 citations indexed

About

Hardeep S. Oberoi is a scholar working on Biomaterials, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Hardeep S. Oberoi has authored 18 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Biomaterials, 8 papers in Molecular Biology and 5 papers in Pharmaceutical Science. Recurrent topics in Hardeep S. Oberoi's work include Nanoparticle-Based Drug Delivery (11 papers), Advanced Drug Delivery Systems (5 papers) and Drug Solubulity and Delivery Systems (4 papers). Hardeep S. Oberoi is often cited by papers focused on Nanoparticle-Based Drug Delivery (11 papers), Advanced Drug Delivery Systems (5 papers) and Drug Solubulity and Delivery Systems (4 papers). Hardeep S. Oberoi collaborates with scholars based in United States, Russia and Canada. Hardeep S. Oberoi's co-authors include Alexander V. Kabanov, Tatiana K. Bronich, N. V. Nukolova, Samuel M. Cohen, Luis A. Marky, Jay T. Evans, David J. Burkhart, Jong Oh Kim, Yi Zhao and В. П. Чехонин and has published in prestigious journals such as Biomaterials, Advanced Drug Delivery Reviews and Journal of Controlled Release.

In The Last Decade

Hardeep S. Oberoi

18 papers receiving 899 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hardeep S. Oberoi United States 11 568 305 272 164 155 18 909
Yong‐Ho Shim South Korea 12 602 1.1× 283 0.9× 294 1.1× 160 1.0× 105 0.7× 23 977
Catherine Passirani France 18 565 1.0× 432 1.4× 385 1.4× 196 1.2× 158 1.0× 20 1.1k
Huaiyu Liu China 11 743 1.3× 408 1.3× 470 1.7× 139 0.8× 132 0.9× 13 1.1k
Gahininath Y. Bharate Japan 5 605 1.1× 389 1.3× 375 1.4× 119 0.7× 130 0.8× 7 993
Changying Shi United States 17 475 0.8× 376 1.2× 302 1.1× 219 1.3× 109 0.7× 37 1.0k
Francesca Mastrotto Italy 20 388 0.7× 447 1.5× 279 1.0× 161 1.0× 89 0.6× 59 1.0k
Moo J. Cho United States 11 438 0.8× 460 1.5× 262 1.0× 137 0.8× 121 0.8× 21 1.0k
Pelin Mutlu Türkiye 13 427 0.8× 289 0.9× 273 1.0× 83 0.5× 113 0.7× 37 802
Nate Larson United States 9 523 0.9× 320 1.0× 391 1.4× 157 1.0× 116 0.7× 10 878
Duhyeong Hwang United States 14 350 0.6× 309 1.0× 217 0.8× 157 1.0× 80 0.5× 25 875

Countries citing papers authored by Hardeep S. Oberoi

Since Specialization
Citations

This map shows the geographic impact of Hardeep S. Oberoi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hardeep S. Oberoi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hardeep S. Oberoi more than expected).

Fields of papers citing papers by Hardeep S. Oberoi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hardeep S. Oberoi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hardeep S. Oberoi. The network helps show where Hardeep S. Oberoi may publish in the future.

Co-authorship network of co-authors of Hardeep S. Oberoi

This figure shows the co-authorship network connecting the top 25 collaborators of Hardeep S. Oberoi. A scholar is included among the top collaborators of Hardeep S. Oberoi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hardeep S. Oberoi. Hardeep S. Oberoi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhou, Deliang, et al.. (2024). Scale-up and clinical bioavailability assessment of a 45% drug loaded amorphous nanoparticle formulation of a BCS IV compound for oral delivery. Journal of Pharmaceutical Sciences. 114(1). 383–393. 1 indexed citations
2.
Clogston, Jeffrey D., Willard R. Foss, David Harris, et al.. (2024). Current state of nanomedicine drug products: An industry perspective. Journal of Pharmaceutical Sciences. 113(12). 3395–3405. 17 indexed citations
3.
Purohit, Hitesh S., Deliang Zhou, Hardeep S. Oberoi, et al.. (2023). Proof-of-Concept in Developing a 45% Drug Loaded Amorphous Nanoparticle Formulation. Journal of Pharmaceutical Sciences. 113(4). 1007–1019. 7 indexed citations
4.
Oberoi, Hardeep S., et al.. (2023). Design of Redispersible High-Drug-Load Amorphous Formulations: Impact of Ionic vs Nonionic Surfactants on Processing and Performance. Molecular Pharmaceutics. 20(11). 5827–5841. 5 indexed citations
5.
Oberoi, Hardeep S., et al.. (2022). Design of a Re-Dispersible High Drug Load Amorphous Formulation. Journal of Pharmaceutical Sciences. 112(1). 250–263. 8 indexed citations
6.
7.
Oberoi, Hardeep S., et al.. (2015). Methylglycol chitosan and a synthetic TLR4 agonist enhance immune responses to influenza vaccine administered sublingually. Vaccine. 33(43). 5845–5853. 20 indexed citations
8.
Oberoi, Hardeep S., N. V. Nukolova, Alexander V. Kabanov, & Tatiana K. Bronich. (2013). Nanocarriers for delivery of platinum anticancer drugs. Advanced Drug Delivery Reviews. 65(13-14). 1667–1685. 334 indexed citations
9.
Kim, Jong Oh, Hardeep S. Oberoi, Swapnil S. Desale, Alexander V. Kabanov, & Tatiana K. Bronich. (2013). Polypeptide nanogels with hydrophobic moieties in the cross-linked ionic cores: synthesis, characterization and implications for anticancer drug delivery. Journal of drug targeting. 21(10). 981–993. 28 indexed citations
10.
Nukolova, N. V., Hardeep S. Oberoi, Yi Zhao, et al.. (2013). LHRH-Targeted Nanogels as a Delivery System for Cisplatin to Ovarian Cancer. Molecular Pharmaceutics. 10(10). 3913–3921. 51 indexed citations
11.
Oberoi, Hardeep S., N. V. Nukolova, Larisa Y. Poluektova, et al.. (2012). Cisplatin-loaded core cross-linked micelles: comparative pharmacokinetics, antitumor activity, and toxicity in mice. International Journal of Nanomedicine. 7. 2557–2557. 51 indexed citations
12.
Oberoi, Hardeep S., N. V. Nukolova, Yi Zhao, et al.. (2012). Preparation and In Vivo Evaluation of Dichloro(1,2-Diaminocyclohexane)platinum(II)-Loaded Core Cross-Linked Polymer Micelles. PubMed. 2012. 1–10. 17 indexed citations
13.
Nukolova, N. V., Hardeep S. Oberoi, Samuel M. Cohen, Alexander V. Kabanov, & Tatiana K. Bronich. (2011). Folate-decorated nanogels for targeted therapy of ovarian cancer. Biomaterials. 32(23). 5417–5426. 193 indexed citations
14.
Oberoi, Hardeep S., et al.. (2011). Core cross-linked block ionomer micelles as pH-responsive carriers for cis-diamminedichloroplatinum(II). Journal of Controlled Release. 153(1). 64–72. 87 indexed citations
15.
Oberoi, Hardeep S., N. V. Nukolova, & Tatiana K. Bronich. (2011). Dichloro(1,2-Diaminocyclohexane)Platinum(II) (DACHPt) Loaded Polymer Micelles with Cross-Linked Core: Preparation and Characterization.. PubMed. 104. 630–631. 3 indexed citations
16.
Oberoi, Hardeep S., et al.. (2009). Nitrate assimilatory enzymes of Spirulina (Arthospira) platensis are more thermotolerant than those of rice. Physiology and Molecular Biology of Plants. 15(3). 277–280. 3 indexed citations
17.
Kim, Jong Oh, N. V. Nukolova, Hardeep S. Oberoi, Alexander V. Kabanov, & Tatiana K. Bronich. (2009). Block ionomer complex micelles with cross-linked cores for drug delivery. Polymer Science Series A. 51(6). 708–718. 33 indexed citations
18.
Kim, Jong Oh, Hardeep S. Oberoi, & Tatiana K. Bronich. (2009). CROSS-LINKED POLYMER MICELLES WITH BIODEGRADABLE IONIC CORES FOR ANTI-CANCER DRUG DELIVERY.. PubMed. 50(2). 372–373. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yong‐Ho Shim Breakdown of academic impact, for papers by Catherine Passirani Breakdown of academic impact, for papers by Huaiyu Liu Breakdown of academic impact, for papers by Gahininath Y. Bharate Breakdown of academic impact, for papers by Changying Shi Breakdown of academic impact, for papers by Francesca Mastrotto Breakdown of academic impact, for papers by Moo J. Cho Breakdown of academic impact, for papers by Pelin Mutlu Breakdown of academic impact, for papers by Nate Larson Breakdown of academic impact, for papers by Duhyeong Hwang
Rankless by CCL
2026